NFKB1 and Optic neuropathy: We provide a new insight into the role of NF-κBp50 in the pathophysiologyof optic neuropathy, and present experiments involving p50-deficient mice demonstrating the CaN-signaling molecules including NF-κB, suggesting targets for the development of therapeutic reagents.